Beck Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Beck Capital Management's LLY Position: Q2 2026 in Review
Beck Capital Management increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $168K and bringing the position to 6,366 shares worth $7.64M. The position accounts for 1.41% of the portfolio, ranked #25.
Beck Capital Management first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $8.08M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Beck Capital Management held 6,366 shares of Eli Lilly worth $7.64M as of Q2 2026.
- Beck Capital Management bought 164 Eli Lilly shares in Q2 2026, an estimated $168K.
- Eli Lilly made up 1.41% of Beck Capital Management's portfolio in Q2 2026, its #25 holding.
- Beck Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- Beck Capital Management's Eli Lilly position peaked at $8.08M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Beck Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.